Overall rank by patents
#19,585
of 50,000 tracked assignees
USPTO PatentsView assignee record - 14 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
The verdict
According to USPTO PatentsView, Cellresearch ranks #19,585 of 50,000 tracked US assignees by granted-patent volume, with 14 patents across 8 technology areas.
USPTO PatentsView assignee plate
Corpus R19585 · Foreign Corporation #19,585 · 14 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Celagenex Research (india) PVT. Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Brooks Sports · near
28 score
Celadon Systems · near
28 score
Cellresearch PTE · this assignee
28 score
Tung Hing Plastic Ma… · near
28 score
Zero Friction · near
28 score
3D Lighting Innovati… · lowest
7 score
What this shows Cellresearch Corporation PTE. Ltd. stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-NARROW, INNOV-THIN, CLAIMS-PAR, TYPE-FRNCORP, VEL-DOWN, BOOK-FULL. Volume places it #19,585 of 50,000; Innovation Score 28.2/100 sits in the top 73% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Celagenex Research (india) PVT. Ltd. (±0 grants).
Cellresearch Corporation PTE. Ltd. has been granted 14 US utility patents between 2015 and 2025, placing Cellresearch Corporation PTE. Ltd. at #19,585 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.1 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, Cellresearch Corporation PTE. Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Cellresearch sits between Celagenex Research (india) PVT. Ltd. (14 patents, rank #19,566) and Checkmate Lifting & Safety Ltd (14 patents, rank #19,574) - the closest US assignees by grant volume. The composite Innovation Score of 28.2/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 6 grants, compared with 7 in the 2015–2019 window, a -14% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Cellresearch Corporation PTE. Ltd.'s 8.1 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 8 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CELAGENEX RESEARCH (INDIA) PVT. LTD.
14 patents
CELERINT, LLC
14 patents
CELLCENTRIC GMBH & CO. KG
14 patents
CELLIVERY THERAPEUTICS, INC.
14 patents
CEMPRA PHARMACEUTICALS, INC.
14 patents
CERTIS CISCO SECURITY PTE LTD
14 patents
CERTOPLAST TECHNISCHE KLEBEBAENDER GMBH
14 patents
CHECKMATE LIFTING & SAFETY LTD
14 patents
CELLRESEARCH CORPORATION PTE. LTD.
14 patents
What this shows Cellresearch holds 14 patents at rank #19,570, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #19,570 in granted patent volume.
Other assignees with the most granted patents in Cellresearch's primary technology class.
Two PlainPatent-derived peer sets for Cellresearch, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (28 here).
Cellresearch's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 Top 73% higher than 27% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 14.3% |
| 2017 | 2 | 14.3% |
| 2018 | 1 | 7.1% |
| 2019 | 2 | 14.3% |
| 2020 | 1 | 7.1% |
| 2021 | 2 | 14.3% |
| 2022 | 1 | 7.1% |
| 2023 | 1 | 7.1% |
| 2024 | 1 | 7.1% |
| 2025partial year | 1 | 7.1% |
Top 8 of 8 technology areas
Overall rank by patents
#19,585
of 50,000 tracked assignees
28.2 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.